HK1201520A1 - Antibacterial quinoline derivatives - Google Patents
Antibacterial quinoline derivativesInfo
- Publication number
- HK1201520A1 HK1201520A1 HK15101961.6A HK15101961A HK1201520A1 HK 1201520 A1 HK1201520 A1 HK 1201520A1 HK 15101961 A HK15101961 A HK 15101961A HK 1201520 A1 HK1201520 A1 HK 1201520A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quinoline derivatives
- antibacterial quinoline
- antibacterial
- derivatives
- quinoline
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12165882 | 2012-04-27 | ||
| PCT/EP2013/058697 WO2013160431A1 (en) | 2012-04-27 | 2013-04-26 | Antibacterial quinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1201520A1 true HK1201520A1 (en) | 2015-09-04 |
Family
ID=48325651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15101961.6A HK1201520A1 (en) | 2012-04-27 | 2015-02-27 | Antibacterial quinoline derivatives |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9617244B2 (xx) |
| EP (1) | EP2841426B1 (xx) |
| JP (1) | JP6153603B2 (xx) |
| KR (1) | KR102110366B1 (xx) |
| CN (1) | CN104254528B (xx) |
| AU (1) | AU2013254670B2 (xx) |
| CA (1) | CA2869453C (xx) |
| DK (1) | DK2841426T3 (xx) |
| EA (1) | EA038350B1 (xx) |
| ES (1) | ES2607879T3 (xx) |
| HK (1) | HK1201520A1 (xx) |
| IN (1) | IN2014MN02358A (xx) |
| MX (1) | MX358506B (xx) |
| PL (1) | PL2841426T3 (xx) |
| PT (1) | PT2841426T (xx) |
| WO (1) | WO2013160431A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX355050B (es) * | 2012-04-27 | 2018-04-02 | Janssen Pharmaceutica Nv | Derivados de quinolina antibacterianos. |
| WO2018048882A1 (en) | 2016-09-06 | 2018-03-15 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
| AU2023235233A1 (en) | 2022-03-14 | 2024-09-12 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| JP7536376B1 (ja) | 2024-05-27 | 2024-08-20 | 信一 安羅岡 | ロータリー耕うん装置 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0936866A4 (en) | 1996-10-28 | 2001-04-11 | Dept Of The Army Us Government | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING ANTIBIOTIC RESIST INFECTIONS |
| US6103905A (en) | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
| JP4484703B2 (ja) | 2002-07-25 | 2010-06-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | キノリン誘導体およびミコバクテリア抑制剤としてのそれらの使用 |
| ATE392423T1 (de) * | 2004-01-23 | 2008-05-15 | Janssen Pharmaceutica Nv | Substituierte chinoline und deren verwendung als inhibitoren von mycobakterien |
| EA011277B1 (ru) | 2004-01-23 | 2009-02-27 | Янссен Фармацевтика Н.В. | Производные хинолина и их применение в качестве ингибиторов микобактерий |
| WO2005075428A1 (en) | 2004-01-29 | 2005-08-18 | Janssen Pharmaceutica N.V. | Quinoline derivatives for use as mycobacterial inhibitors |
| KR20130024969A (ko) | 2004-05-28 | 2013-03-08 | 얀센 파마슈티카 엔.브이. | 약물 내성 마이코박테리아 질환 치료를 위한 치환된 퀴놀린 유도체의 용도 |
| WO2005123081A2 (en) | 2004-06-22 | 2005-12-29 | Janssen Pharmaceutica N.V. | (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia |
| CN101065397B (zh) | 2004-09-28 | 2015-10-21 | 詹森药业有限公司 | 一种细菌atp合酶的结合结构域 |
| EE05394B1 (et) | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| EE05697B1 (et) | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
| JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO3270B1 (ar) | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
| RS55601B1 (sr) | 2005-06-28 | 2017-06-30 | Janssen Pharmaceutica Nv | Derivati kvinolina kao antibakterijski agensi |
| JO3077B1 (ar) | 2005-07-28 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينولين مضادة للبكتيريا |
| JO2952B1 (en) | 2005-08-03 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2855B1 (en) | 2005-08-03 | 2015-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO2683B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2685B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO3271B1 (ar) | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2684B1 (en) | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان في | Quinoline antibacterial derivatives |
| JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| WO2009091324A1 (en) * | 2008-01-14 | 2009-07-23 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| MX355050B (es) * | 2012-04-27 | 2018-04-02 | Janssen Pharmaceutica Nv | Derivados de quinolina antibacterianos. |
-
2013
- 2013-04-26 CN CN201380021822.1A patent/CN104254528B/zh active Active
- 2013-04-26 PL PL13720875T patent/PL2841426T3/pl unknown
- 2013-04-26 ES ES13720875.7T patent/ES2607879T3/es active Active
- 2013-04-26 US US14/391,034 patent/US9617244B2/en active Active
- 2013-04-26 JP JP2015507547A patent/JP6153603B2/ja active Active
- 2013-04-26 DK DK13720875.7T patent/DK2841426T3/en active
- 2013-04-26 EA EA201491971A patent/EA038350B1/ru unknown
- 2013-04-26 EP EP13720875.7A patent/EP2841426B1/en active Active
- 2013-04-26 MX MX2014013055A patent/MX358506B/es active IP Right Grant
- 2013-04-26 AU AU2013254670A patent/AU2013254670B2/en active Active
- 2013-04-26 CA CA2869453A patent/CA2869453C/en active Active
- 2013-04-26 IN IN2358MUN2014 patent/IN2014MN02358A/en unknown
- 2013-04-26 KR KR1020147030645A patent/KR102110366B1/ko active IP Right Grant
- 2013-04-26 PT PT137208757T patent/PT2841426T/pt unknown
- 2013-04-26 WO PCT/EP2013/058697 patent/WO2013160431A1/en active Application Filing
-
2015
- 2015-02-27 HK HK15101961.6A patent/HK1201520A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2841426A1 (en) | 2015-03-04 |
| WO2013160431A1 (en) | 2013-10-31 |
| PL2841426T3 (pl) | 2017-03-31 |
| EA038350B1 (ru) | 2021-08-12 |
| US9617244B2 (en) | 2017-04-11 |
| JP6153603B2 (ja) | 2017-06-28 |
| CA2869453C (en) | 2021-03-02 |
| CA2869453A1 (en) | 2013-10-31 |
| CN104254528B (zh) | 2017-06-06 |
| JP2015514795A (ja) | 2015-05-21 |
| US20150051244A1 (en) | 2015-02-19 |
| PT2841426T (pt) | 2016-11-23 |
| EA201491971A1 (ru) | 2015-02-27 |
| KR102110366B1 (ko) | 2020-05-14 |
| MX2014013055A (es) | 2014-12-10 |
| EP2841426B1 (en) | 2016-09-28 |
| IN2014MN02358A (xx) | 2015-08-14 |
| MX358506B (es) | 2018-08-22 |
| KR20150013148A (ko) | 2015-02-04 |
| DK2841426T3 (en) | 2017-01-09 |
| AU2013254670A1 (en) | 2014-10-16 |
| CN104254528A (zh) | 2014-12-31 |
| AU2013254670B2 (en) | 2017-03-30 |
| ES2607879T3 (es) | 2017-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
| HK1211022A1 (en) | Novel quinolone derivatives | |
| HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
| HK1206031A1 (en) | Antibacterial compounds | |
| ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| HK1205514A1 (en) | Antibacterial quinoline derivatives | |
| HK1200824A1 (en) | Substituted phenylazole derivative | |
| HK1201520A1 (en) | Antibacterial quinoline derivatives | |
| EP2882430A4 (en) | ANTIBACTERIAL INHIBITORS | |
| GB201206384D0 (en) | Antibacterial drug derivatives | |
| ZA201501640B (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
| HK1210954A1 (en) | Antibacterial compounds | |
| IL239207A0 (en) | Antibacterial compounds | |
| GB201206385D0 (en) | Antibacterial drug derivatives | |
| GB201206383D0 (en) | Antibacterial drug derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230420 |